What began as a mountain biking accident<\/strong> nearly became a life-altering misdiagnosis for Andy Provencher<\/strong>, a father of three. After crashing over his handlebars in June 2020, Provencher was rushed to the emergency room with broken bones and a punctured lung. But imaging scans revealed something far more alarming \u2014 multiple masses throughout his lungs<\/strong>, leading doctors to suspect aggressive, terminal lung cancer<\/strong>.<\/p>\n\n\n\n The shocking news launched a year-long medical mystery<\/strong>, as repeated tests and biopsies failed to confirm cancer, yet no alternative explanation could fully account for his symptoms.<\/p>\n\n\n\n Over the following months, Provencher visited primary care physicians, pulmonologists, hematologists, and rheumatologists<\/strong>, only to receive conflicting opinions. While cancer was frequently suggested, no diagnosis was definitive.<\/p>\n\n\n\n Meanwhile, his physical condition deteriorated rapidly. He experienced severe fatigue, muscle pain, shortness of breath<\/strong>, and difficulty climbing stairs. Doctors eventually advised him to prepare for chemotherapy<\/strong>, despite the lack of a confirmed diagnosis.<\/p>\n\n\n\n Just two weeks before beginning chemotherapy, an unexpected insight changed everything. A physician assistant studying rheumatology recognized that Provencher\u2019s symptoms matched those of IgG4-Related Disease (IgG4-RD)<\/strong> \u2014 a rare immune-mediated inflammatory condition<\/strong>.<\/p>\n\n\n\n After consulting with a leading rheumatology specialist and undergoing targeted testing, Provencher finally received an accurate diagnosis. The moment brought instant relief after a year of uncertainty, fear, and emotional strain.<\/p>\n\n\n\n IgG4-RD<\/strong> is a rare autoimmune condition that can cause inflammation, tissue scarring, and organ damage<\/strong> throughout the body. It may affect the lungs, pancreas, liver, lymph nodes, salivary glands, eyes, and nervous system<\/strong>, often progressing slowly and silently.<\/p>\n\n\n\n Because there is no single blood test or biopsy that confirms IgG4-RD<\/strong>, patients are frequently misdiagnosed with cancer or other chronic illnesses. Many endure years of symptoms before receiving the correct diagnosis.<\/p>\n\n\n\n Provencher enrolled in a groundbreaking clinical trial<\/strong> testing inebilizumab<\/strong>, a monoclonal antibody therapy designed to deplete B cells involved in immune dysfunction.<\/p>\n\n\n\n The results were transformative. Patients receiving inebilizumab experienced:<\/p>\n\n\n\n In April 2025<\/strong>, inebilizumab became the first FDA-approved treatment for IgG4-Related Disease<\/strong>, marking a major breakthrough for patients worldwide.<\/p>\n\n\n\n Now several years into treatment, Provencher reports improved energy levels and a renewed ability to enjoy time with his family. While IgG4-RD has no permanent cure<\/strong>, the disease can enter remission with proper treatment and monitoring.<\/p>\n\n\n\n Determined to help others avoid delayed diagnoses, Provencher and his family have become active advocates for IgG4-RD awareness<\/strong>, emphasizing early recognition, education, and persistence in seeking answers.<\/p>\n\n\n\n Provencher\u2019s experience offers a powerful reminder: IgG4-Related Disease, rare autoimmune disease, lung cancer misdiagnosis, immune disorder diagnosis, IgG4-RD symptoms, FDA approved IgG4 treatment, inebilizumab therapy, delayed medical diagnosis, rare disease awareness, autoimmune inflammation<\/p>\n","protected":false},"excerpt":{"rendered":" Misdiagnosed as Terminal Cancer After a Bike Accident What began as a mountain biking accident nearly became a life-altering misdiagnosis for Andy Provencher, a father of three. After crashing over his handlebars in June 2020, Provencher was rushed to the emergency room with broken bones and a punctured lung. But imaging scans revealed something far […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"saved_in_kubio":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2717","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/sportpro.cc\/index.php?rest_route=\/wp\/v2\/posts\/2717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sportpro.cc\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sportpro.cc\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sportpro.cc\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/sportpro.cc\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2717"}],"version-history":[{"count":1,"href":"https:\/\/sportpro.cc\/index.php?rest_route=\/wp\/v2\/posts\/2717\/revisions"}],"predecessor-version":[{"id":2718,"href":"https:\/\/sportpro.cc\/index.php?rest_route=\/wp\/v2\/posts\/2717\/revisions\/2718"}],"wp:attachment":[{"href":"https:\/\/sportpro.cc\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sportpro.cc\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sportpro.cc\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}A Year of Conflicting Diagnoses and Declining Health<\/h3>\n\n\n\n
A Chance Suggestion Leads to a Rare Disease Discovery<\/h3>\n\n\n\n
What Is IgG4-Related Disease (IgG4-RD)?<\/h3>\n\n\n\n
Breakthrough Treatment and FDA-Approved Therapy<\/h3>\n\n\n\n
\n
Life After Diagnosis: Recovery, Advocacy, and Awareness<\/h3>\n\n\n\n
A Message for Patients Facing Uncertainty<\/h3>\n\n\n\n
Question diagnoses, seek second opinions, and keep moving forward.<\/strong> Rare diseases often hide behind common symptoms, and one informed suggestion can change everything.<\/p>\n\n\n\n
\n\n\n\nSEO Keyword Suggestions<\/h3>\n\n\n\n